{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:02:38Z","timestamp":1788346958747,"version":"build-2803163510"},"reference-count":0,"publisher":"American Diabetes Association","issue":"5","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[1970,5,1]]},"abstract":"<jats:p>A negative urinary glucose oxidase test in the presence of glucbsuria may occur in patients with alcaptonuria or the carcinoid syndrome. It may also be noted after ingestion of aspirin or L-dopa. The responsible agents are potent reducing metabolites such as gentisic acid, homogentisic acid, or 5-hydroxyindole acetic acid. These agents produce the misleading reaction by keeping the indicator dye o-tolidine in its reduced form. In the presence of such reducing agents the tests for glucosuria should be carried out either with Tes-Tape or by modifying the manufacturer's instructions and only partially immersing the Clinistix strip.<\/jats:p>","DOI":"10.2337\/diab.19.5.337","type":"journal-article","created":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T05:58:24Z","timestamp":1418277504000},"page":"337-343","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":26,"title":["Inhibition of Glucose Oxidase Paper Tests by Reducing Metabolites"],"prefix":"10.2337","volume":"19","author":[{"given":"Jerome M","family":"Feldman","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Duke University Medical Center\u2008Durham, North Carolina 27706"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William N","family":"Kelley","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Duke University Medical Center\u2008Durham, North Carolina 27706"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold E","family":"Lebovitz","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Duke University Medical Center\u2008Durham, North Carolina 27706"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/19\/5\/337\/335644\/19-5-337.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/19\/5\/337\/335644\/19-5-337.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:17:02Z","timestamp":1667405822000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/19\/5\/337\/3412\/Inhibition-of-Glucose-Oxidase-Paper-Tests-by"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1970,5,1]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1970,5,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diab.19.5.337","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1970,5,1]]}}}